TocilizumabV1, 2020, Analysis, indexHead, Title.i

Index : Titre (en)

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

167	covid
122	patients
105	arthritis
103	tocilizumab
96	treatment
88	disease
78	rheumatoid
57	cell
55	therapy
51	review
49	clinical
38	receptor
36	case
35	management
35	coronavirus
34	anti
32	syndrome
31	diseases
30	acute
28	new
28	infection
27	therapeutic
27	severe
27	sars
27	cov
26	drugs
26	cells
25	refractory
25	patient
25	associated
24	report
24	immune
24	arteritis
23	risk
23	interleukin
22	systemic
21	safety
21	role
21	inflammatory
21	induced
20	rheumatic
20	response
20	chimeric
20	cancer
20	antigen
19	treated
19	systematic
19	efficacy
19	cytokine
18	potential
18	pandemic
18	idiopathic
18	biologic
17	diagnosis
17	analysis
17	after
16	novel
16	juvenile
16	inhibitor
16	biological
15	trial
15	modifying
15	lung
15	drug
15	car
14	transplant
14	therapies
14	related
14	experience
14	cohort
14	cardiovascular
13	transplantation
13	literature
13	kidney
13	inhibitors
13	inflammation
13	giant
13	early
13	antirheumatic
13	antibody
12	real
12	phase
12	factor
12	chronic
11	update
11	targeting
11	takayasu
11	sclerosis
11	relapsed
11	recommendations
11	onset
11	interstitial
11	implications
11	evidence
11	effectiveness
11	during
11	data
11	children
11	autoimmune
10	stem
10	retrospective
10	results
10	release
10	pulmonary
10	possible
10	pneumonia
10	pediatric
10	outcomes
10	leukemia
10	large
10	impact
10	factors
10	effect
10	center
10	care
10	agents
10	adult
9	type
9	synthetic
9	successful
9	rheumatology
9	options
9	necrosis
9	mediated
9	expression
9	against
9	activation
8	versus
8	trials
8	tnf
8	term
8	targeted
8	system
8	still
8	signaling
8	practice
8	pathogenesis
8	non
8	model
8	injury
8	immunotherapy
8	effects
8	checkpoint
8	characteristics
8	castleman
8	adverse
8	adults
7	virus
7	tumor
7	tissue
7	states
7	respiratory
7	renal
7	people
7	pathway
7	monitoring
7	lymphoma
7	long
7	joint
7	italy
7	inhibition
7	ill
7	human
7	heart
7	failure
7	critically
7	complications
7	biomarkers
7	antibodies
6	viral
6	treatments
6	studies
6	spectrum
6	single
6	serum
6	registry
6	receiving
6	randomized
6	observational
6	methotrexate
6	meta
6	macrophage
6	lymphoblastic
6	life
6	know
6	infections
6	hospital
6	high
6	hematopoietic
6	following
6	first
6	fibrosis
6	events
6	emerging
6	development
6	cytokines
6	controlled
6	cases
6	blockade
6	biologics
6	assessment
6	approaches
6	advances
5	world
5	uveitis
5	time
5	target
5	syndromes
5	survival
5	subcutaneous
5	status
5	should
5	series
5	sepsis
5	secondary
5	recipients
5	rapid
5	prospective
5	progression
5	narrative
5	multiple
5	monotherapy
5	label
5	initial
5	influence
5	infectious
5	immunogenicity
5	hepatitis
5	hemophagocytic
5	graves
5	gastrointestinal
5	evaluation
5	european
5	encephalitis
5	effective
5	disorders
5	developing
5	cross
5	considerations
5	complicated
5	china
5	challenges
5	bone
5	association
5	approach
5	amyloidosis
5	activity
4	year
4	without
4	vaccine
4	united
4	undergoing
4	treating
4	tofacitinib
4	successfully
4	strategies
4	storm
4	special
4	society
4	site
4	sectional
4	schizophrenia
4	rheumatologists
4	resistant
4	reduced
4	recent
4	protein
4	promotes
4	progress
4	pour
4	pilot
4	perspective
4	orbitopathy
4	option
4	optica
4	obesity
4	neuromyelitis
4	myeloma
4	multicentric
4	multicentre
4	multicenter
4	mediterranean
4	mechanism
4	lymphohistiocytosis
4	liver
4	like
4	levels
4	learned
4	laboratory
4	jak
4	involvement
4	insights
4	host
4	hospitalized
4	hiv
4	health
4	guidelines
4	global
4	french
4	fever
4	eular
4	diabetes
4	consensus
4	connective
4	comprehensive
4	complicating
4	comparison
4	comparative
4	combination
4	ciloleucel
4	cellular
4	caused
4	blood
4	axicabtagene
4	alpha
4	allogeneic
4	advanced
4	active
4	abatacept
3	vessel
3	vasculitis
3	utility
3	understanding
3	under
3	ulcerative
3	tumour
3	tuberculosis
3	toxicity
3	tolerance
3	tlr
3	tisagenlecleucel
3	through
3	tgf
3	targets
3	tafro
3	symptoms
3	switching
3	sustained
3	strategy
3	stat
3	signalling
3	secretion
3	scleritis
3	rheumatica
3	reports
3	remission
3	rejection
3	regulation
3	reducing
3	reduce
3	rat
3	randomised
3	protocol
3	presenting
3	predicting
3	population
3	polymyalgia
3	pharmacological
3	perspectives
3	party
3	pain
3	ovarian
3	other
3	organ
3	open
3	old
3	negative
3	need
3	natural
3	nationwide
3	national
3	multi
3	mri
3	monoclonal
3	modulation
3	moderate
3	mimicking
3	microrna
3	medical
3	may
3	marrow
3	manifestations
3	managing
3	lupus
3	lessons
3	lesson
3	korea
3	killer
3	italian
3	isolated
3	interplay
3	immunosuppressive
3	immunity
3	imaging
3	hypertension
3	hydroxychloroquine
3	herpesvirus
3	gut
3	graft
3	grading
3	glucocorticoid
3	focus
3	flare
3	fibroblast
3	features
3	familial
3	extracorporeal
3	etanercept
3	era
3	elevated
3	ebmt
3	does
3	discontinuation
3	different
3	derived
3	delayed
3	death
3	cutaneous
3	crs
3	could
3	cost
3	correlation
3	coronary
3	conventional
3	control
3	con
3	collagen
3	colitis
3	choroidal
3	chloroquine
3	chinese
3	childhood
3	challenge
3	cardiac
3	but
3	bilateral
3	antagonist
3	animal
3	angiotensin
3	american
3	alternative
3	administration
3	adalimumab
2	years
2	working
2	within
2	why
2	when
2	vitro
2	vitamin
2	via
2	usefulness
2	useful
2	upregulation
2	updated
2	uncertainty
2	turnover
2	turkey
2	treg
2	treat
2	transcriptomic
2	traitement
2	tract
2	toxicities
2	thrombocytopenia
2	test
2	tertiary
2	taiwan
2	symptomatic
2	surviving
2	surgery
2	suppression
2	subjects
2	stimulating
2	stenosis
2	statement
2	starting
2	stage
2	spinal
2	specifically
2	south
2	small
2	serious
2	seattle
2	score
2	scleroderma
2	sarcoma
2	sarcoidosis
2	salvage
2	rituximab
2	retention
2	responses
2	repurposing
2	replication
2	reperfusion
2	relevance
2	regulated
2	reference
2	recurrent
2	recipient

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/2020/Analysis/Title.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab - Analysis (2020) Index « Titre (en) » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab - Analysis (2020)Index « Titre (en) » - tête de navigation

Index : Titre (en)

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - tête de navigation